scispace - formally typeset
K

Kayhan Bolelli

Researcher at Ankara University

Publications -  27
Citations -  329

Kayhan Bolelli is an academic researcher from Ankara University. The author has contributed to research in topics: Pharmacophore & Benzoxazole. The author has an hindex of 8, co-authored 25 publications receiving 248 citations. Previous affiliations of Kayhan Bolelli include Mercer University.

Papers
More filters
Journal ArticleDOI

Synthesis, biological evaluation and 2D-QSAR analysis of benzoxazoles as antimicrobial agents.

TL;DR: A new series of 5(or 6)-nitro/amino-2-(substituted phenyl/benzyl)benzoxazole derivatives synthesized and evaluated for antibacterial and antifungal activities against Staphylococcus aureus, Bacillus subtilis, Klebsiella pneumoniae, Pseudomonas aeruginosa, Escherichia coli, Candida albicans and their drug-resistant isolate.
Journal ArticleDOI

Vibrational spectroscopic (FT-IR, FT-Raman, ^{1}H NMR and UV) investigations and computational study of 5-nitro-2-(4-nitrobenzyl) benzoxazole

TL;DR: The optimized molecular structure, vibrational frequencies, corresponding vibrational assignments of 5-nitro-2-(4-Nitrobenzyl) benzoxazole have been investigated experimentally and theoretically using Gaussian09 software package and the calculated geometrical parameters are in agreement with that of similar derivatives.
Journal ArticleDOI

Quantum Mechanical Studies of Three Aromatic Halogen-Substituted Bioactive Sulfonamidobenzoxazole Compounds with Potential Light Harvesting Properties

TL;DR: Three different organic compounds, 2-phenyl-5-(4-trifloromethyl phenyl sulfonamido) benzoxazole (PTPS), 2-(4chlorobenzyl)-5-(2,4-dinitrophenylsulfonamide)benzoxazoles (CNSB) and 2-( 4-fluorobenzyl)-...
Journal ArticleDOI

Synthesis and biological evaluation of 2-substituted-5-(4-nitrophenylsulfonamido)benzoxazoles as human GST P1-1 inhibitors, and description of the binding site features.

TL;DR: The design and synthesis of some novel sulfonamide‐containing benzoxazoles, which are able to inhibit human GST P1‐1 are reported, and 2‐(4‐chlorobenzyl)‐5‐ (4‐nitrophenylsulfonamido)benzoxazole (5 f) was found as the most active hGST P 1‐1 inhibitor, with an IC50 value of 10.2 μM, showing
Journal ArticleDOI

Binding site feature description of 2-substituted benzothiazoles as potential AcrAB-TolC efflux pump inhibitors in E. coli.

TL;DR: A set of BSN-coded 2-substituted benzothiazoles tested alone and in combinations with ciprofloxacin against the AcrAB-TolC overexpressor Escherichia coli AG102 clinical strain indicated that the BSN compounds did not show intrinsic antimicrobial activity when tested alone, but when used in combination with CIP, a reversal in the antibacterial activity of CIP was observed.